February 14, 2025

Researchers Make the Case for Multimodal, Multimechanism Glaucoma Therapy

"Evidence shows that many patients require more than one treatment to achieve adequate IOP reduction and glaucoma control."

Conexiant

February 14, 2025

Additional Ophthalmic Complications Associated with GLP-1 Use Identified in Case Series

AAO provides guidance in response.

Conexiant

February 14, 2025

Researchers Evaluate AI-based Smart Glasses and Apps in Patients With Vision Impairment

The tools significantly improved participants' ability to complete text-based tasks.

Conexiant

February 14, 2025

Signs of Immunological Memory in Cases of Occlusive Retinal Vasculitis Following Rechallenge with Faricimab

Real-world case series suggests caution with even mild IOI.

Conexiant

February 14, 2025

Researchers Find Minimal Risk of Adverse Events in Mobile Eye Screening Programs

The most common mild, self-resolving symptoms included eye pain and nervousness about procedures.

Conexiant

February 12, 2025

nAMD Patients and Providers Suggest Strategies to Improve Care

Approximately 62% of providers stated in a survey that limited resources and high patient volumes made it difficult to deliver optimal care.

Conexiant

February 11, 2025

Retinal Parameters Associated with Incident Stroke

"Retinal vascular analysis, a non-invasive screening approach for stroke risk assessment, performed better than traditional risk stratification models," researchers wrote.

Conexiant

February 11, 2025

LIGHTSITE III Data Answers and Raises Questions about Photobiomodulation Therapy for AMD

The trial met the primary endpoint with a statistically significant +5.4 letter gain in BCVA and a favorable safety profile, but experts raised additional questions after the FDA cleared marketing for a PBM device.

Conexiant

February 06, 2025

The Emerging Role of Orbital Fat in Inflammatory Orbital Diseases

Literature review cites the production of pro-inflammatory cytokines and other metabolic properties that may contribute to Graves’ orbitopathy ophthalmopathy, sarcoidosis, and other IODs.

Conexiant